This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan
Book Now
Menu
Book Now

Stefan Nilsson, Ph.D.
CEO at Lipigon Pharmaceuticals AB
Speaker

Profile

Stefan has been the CEO since 2016. He holds a doctorate in medicine with a focus on blood lipids and is the founder of Lipigon. He is a biomedical engineer, holds a master's degree in entrepreneurship, and has a background in medicine.

Agenda Sessions

  • Reviving ANGPTL4 As a Drug Target with a GalNAc ASO Approach – A Case Study

    , 3:45pm
    View Session

At this event

Prev
Next
Dr. Christian Adam Olsen, PhD
Professor, Drug Design and Pharmacology
University of Copenhagen

See Stefan at TIDES Asia: Oligonucleotide & Peptide Therapeutics

Book Now